1.
Aung T, Ozaki M, Lee MC, et al. Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet. 2017;49(7):993-1004. doi:10.1038/ng.3875.
1.
Guo L, Kim HJ, Wang H, et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell. 2018;173(3):677-692.e20. doi:10.1016/j.cell.2018.03.002.
1.
Pelka K, Bertheloot D, Reimer E, et al. The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport. Immunity. 2018;48(5):911-922.e7. doi:10.1016/j.immuni.2018.04.011.
1.
Ernst NH, Reeves AZ, Ramseyer JE, Lesser CF. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway. mBio. 2018;9(3). doi:10.1128/mBio.01050-18.
1.
Haining N. Thinking inside the box: how T cell inhibitory receptors signal. Nat Med. 2012;18(9):1338-9. doi:10.1038/nm.2921.
1.
Fu S, Yalcin A, Lee GY, et al. Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity. Sci Transl Med. 2015;7(292):292ra98. doi:10.1126/scitranslmed.aaa9134.